Journal of Disease and Global Health

MYCOBACTERIUM HAEMOPHILUM AND CRYPTOCOCCUS NEOFORMANS COINFECTION IN A SYSTEMIC LUPUS ERYTHEMATOSUS PATIENT

Journal of Disease and Global Health, Volume 15, Issue 2, Page 21-26
DOI: 10.56557/jodagh/2022/v15i27915

Abstract


Mycobacterium haemophilum and Cryptococcus neoformans are human pathogens in immunocompromised individuals. They exhibit a diversity of cutaneous manifestations and could cause disseminated infections. Herein, we report a Thai female with an underlying disease of systemic lupus erythematous, end stage renal disease and hypertension who was on immunosuppressive therapy and diagnosed with disseminated M. haemophilum and C. neoformans coinfection. She presented with multiple indurated plaques on her back, oedematous plaques on both legs and feet with nodules and ulcers on her right leg. She was diagnosed by skin biopsy, acid-fast staining, real-time polymerase chain reaction, tissue culture and haemoculture. A combination of rifampicin, macrolide, fluoroquinolone, amikacin and co-trimoxazole were used to cure M. haemophilum infection. Cryptococcosis was treated with amphotericin B and flucytosine for 5 weeks, then followed by fluconazole. We aim to report a unique dermatological manifestation, microbiology, histopathology, and treatment of the disease. Successful diagnosis and multiple antimicrobials agents are key managements for Mycobacterium haemophilum infection and Cryptococcosis.

Keywords:
  • Coinfection
  • Cryptococcus neoformans
  • immunocompromise
  • infectious skin diseases
  • Mycobacterium haemophilum
  • systemic lupus erythematosus

How to Cite

SAJJACHAREONPONG, N., NOPPAKUN, N., INTALAPAPORN, P., & PUANGPET, P. (2022). MYCOBACTERIUM HAEMOPHILUM AND CRYPTOCOCCUS NEOFORMANS COINFECTION IN A SYSTEMIC LUPUS ERYTHEMATOSUS PATIENT. Journal of Disease and Global Health, 15(2), 21–26. https://doi.org/10.56557/jodagh/2022/v15i27915

References

Lindeboom JA, Bruijnesteijn van Coppenraet LES, van Soolingen D, Prins JM, Kuijper EJ. Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Clinical Microbiology Reviews. 2011 Oct 1;24(4):701–17.

Noguchi H, Matsumoto T, Kimura U, Hiruma M, Kusuhara M, Ihn H. Cutaneous cryptococcosis. Med Mycol J. 2019;60(4):101–7.

Clement CG, Loeffelholz MJ, Eltorky MA, Tang YW, Williams-Bouyer N. Mycobacterium haemophilum and Histoplasma capsulatum coinfection in a renal transplant patient. J Clin Microbiol. 2011 Sep; 49(9):3425–8.

Sayabovorn N, Chongtrakool P, Chayakulkeeree M. Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review. BMC Infect Dis [Internet]. 2021 Jan 7 [cited 2021 Mar 19];21.

Available:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792301/

Teh CL, Kong KO, Chong AP, Badsha H. Mycobacterium haemophilum infection in an SLE patient on mycophenolate mofetil. Lupus. 2002 Apr;11(4):249–52.

Kelley CF, Armstrong WS, Eaton ME. Disseminated Mycobacterium haemophilum infection. The Lancet Infectious Diseases. 2011 Jul;11(7):571–8.

Franco-Paredes C, Marcos LA, Henao-Martínez AF, Rodríguez-Morales AJ, Villamil-Gómez WE, Gotuzzo E, et al. Cutaneous mycobacterial infections. Clinical Microbiology Reviews. 2019;32(1):25.

Nookeu P, Angkasekwinai N, Foongladda S, Phoompoung P. Clinical characteristics and treatment outcomes for patients infected with Mycobacterium haemophilum. Emerg Infect Dis. 2019 Sep;25(9):1648–52.

Oh CC, Pang SM, Busmanis I, Sun S, Sng LH. Mycobacterium haemophilum in an elderly Chinese woman. Int J Dermatol. 2014 Sep; 53(9):1129–32.

Sitenga J, Patel N, Rainwater A. Cutaneous Mycobacterium haemophilum infection involving the upper extremities: Diagnosis and Management Guidelines. 4.

Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15;175(4):367– 416.

Bruijnesteijn van Coppenraet LS, Vincent THBM. Smit, Templeton KE, Claas ECJ, Kuijper EJ. Application of real-time PCR to recognize atypical mycobacteria in archival skin biopsies: High prevalence of Mycobacterium haemophilum. Diagnostic Molecular Pathology. 2007 Jun;16(2): 81–6.

Jing Jing Li, Beresford R, Fyfe J, Henderson C. Clinical and histopathological features of cutaneous nontuberculous mycobacterial infection: a review of 13 cases: LI ET AL. J Cutan Pathol. 2017 May;44(5):433–43.

Lao M, Gong Y, Shen C, Wang C, Liang L, Zhan Z, et al. Infective patterns of cryptococcosis in patients with connective tissue disease: a retrospective study. Clin Rheumatol. 2020 Oct;39(10):3071–81.

Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clinical Infectious Diseases. 2010 Feb 1;50(3):291–322.
  • 0 times
    PDF Download: 0 times

Download Statistics

Downloads

Download data is not yet available.

Current Issue

Subscription

Login to access subscriber-only resources.

Information